Cassava Sciences, Inc. (NASDAQ: SAVA) Stock Information | RedChip

Cassava Sciences, Inc. (NASDAQ: SAVA)


$2.3600
+0.0100 ( -0.59% ) 41.1K

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Market Data


Open


$2.3600

Previous close


$2.3500

Volume


41.1K

Market cap


$113.06M

Day range


$2.3400 - $2.4700

52 week range


$2.2300 - $42.2000

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 74 Aug 08, 2024
8-k 8K-related 15 Jul 22, 2024
8-k 8K-related 15 Jul 18, 2024
8-k 8K-related 15 Jul 17, 2024
8-k 8K-related 14 Jul 01, 2024
8-k 8K-related 15 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024
4 Insider transactions 1 May 22, 2024

Latest News